Are Karnawati Innovation Limited latest results good or bad?

Feb 13 2026 07:54 PM IST
share
Share Via
Karnawati Innovation Limited's latest Q2 FY26 results show a significant turnaround with net sales of ₹20.00 crores and a net profit of ₹1.61 crores, marking a positive recovery after previous inactivity. However, concerns remain about its inconsistent operational history and ongoing structural challenges, making the sustainability of this performance uncertain.
Karnawati Innovation Limited's latest financial results for Q2 FY26 indicate a significant operational turnaround after a prolonged period of inactivity. The company reported net sales of ₹20.00 crores, marking the first meaningful revenue generation since it recorded zero sales in the preceding quarters. This resumption of sales translates into a net profit of ₹1.61 crores, reflecting a substantial quarter-on-quarter improvement.
The operating profit margin for Q2 FY26 stood at 8.05%, which is the highest recorded in recent quarters. Additionally, the company's return on equity (ROE) of 162.71% suggests exceptional capital efficiency, although this figure is contextualized by the company's minimal equity base and inconsistent operational history. The absence of debt further enhances its financial flexibility, as evidenced by a negative debt-to-equity ratio. Despite these positive indicators, the company's operational history raises concerns. The prior fiscal year saw virtually no sales, and the five-year sales growth rate reflects a decline of 39.66%, indicating ongoing structural challenges. The company's valuation metrics, including a high price-to-earnings ratio, suggest that it may be trading at a premium relative to its operational realities. Overall, while Karnawati Innovation Limited's recent results demonstrate a notable recovery, the sustainability of this performance remains uncertain given its past operational inconsistencies. The company has experienced an adjustment in its evaluation, reflecting the market's recognition of both the recent operational recovery and the underlying challenges that persist.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News